Physician's Weekly

JUNE 11, 2025

WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults. “I am very excited and pleased to have Widaplik approved for the treatment of hypertension in the U.S. All rights reserved.

Hypertension 52

Hypertension Diabetes Patients Medical 52

Physician's Weekly

JUNE 22, 2025

Researchers conducted a retrospective study to identify serum proteomic markers that could distinguish between HT, PA, unilateral PA (uPA), and bilateral PA (bPA).

Hypertension 64

Hypertension Individual IT 64

Physician's Weekly

JUNE 18, 2025

WEDNESDAY, June 18, 2025 (HealthDay News) — The Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet with lower sodium is tied to clinically meaningful blood pressure reduction in people with diabetes, according to a study published online June 9 in JAMA Internal Medicine. Pilla, M.D., All rights reserved.

Diabetes 71

Diabetes Internal Medicine Hypertension Clinic 71

Physician's Weekly

JUNE 14, 2025

The following is a summary of “Incidence and Prevalence of Glaucoma, Corticosteroid Response, and Ocular Hypertension in Uveitis and its Anatomical Subtypes,” published in the June 2025 issue of American Journal of Ophthalmology by Marshall et al. The highest rates of ocular hypertension (n=465; 17.9%, 95% CI 16.4-19.3%)

Hypertension 52

Hypertension Diagnose Patients IT 52

Permanente Medicine

JUNE 10, 2025

June 10, 2025) — Maria Ansari, MD, FACC , co-CEO of The Permanente Federation at Kaiser Permanente, has been named to Modern Healthcare’s list of 50 Most Influential Clinical Executives for 2025. Improving access in adult and family medicine at TPMG by reducing appointment booking times by more than 33%.

Clinic 59

Clinic Patient-Centered Healthcare Medical 59

Physician's Weekly

JUNE 24, 2025

The researchers published their findings before the National Lipid Association’s 2025 meeting, though not as part of it. The NLA 2025 meeting included several sessions on hyperlipidemia, including one that focused on FH. Study Methods The researchers selected 469 patients for inclusion in this study.

Patient-Centered 52

Patient-Centered Screening Families Family 52

Today's Hospitalist

JUNE 7, 2025

They presented a rapid clinical update Webinar in May 2025 hosted by the Society of Hospital Medicine. Moreover, because obesity is a chronic disease, “anti-obesity medications should be continued long term, and we can’t stop these medications, just like we wouldn’t stop those for diabetes or hypertension.”

Hospital 66

Hospital Management Diabetes Patients 66